|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/32 | |
| G01N 33/574 |
| (11) | Patento numeris | 2558501 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11716143.0 |
| Europos patento paraiškos padavimo data | 2011-04-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-02-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-09-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/032590 |
| Data | 2011-04-14 |
| (87) | Numeris | WO 2011/130580 |
| Data | 2011-10-20 |
| (30) | Numeris | Data | Šalis |
| 324490 P | 2010-04-15 | US |
| (72) |
ALPER, Ozge, US
|
| (73) |
Alper Biotech, LLC,
9700 Great Seneca Highway Suite 188, Rockville, Maryland 20850,
US
|
| (54) | MONOCLONAL ANTIBODIES AGAINST HER2 ANTIGENS, AND USES THEREFOR |
| MONOCLONAL ANTIBODIES AGAINST HER2 ANTIGENS, AND USES THEREFOR |